Bilal Mujtaba

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Feasibility of half the recommended dose of IV contrast in DECT: image quality evaluation and diagnostic acceptability in cancer patients”.

Feasibility of half the recommended dose of IV contrast in DECT: image quality evaluation and diagnostic acceptability in cancer patients

Clinical Imaging(2022)10.1016/j.clinimag.2022.04.016

N/A

0DataRank · unranked

6 citations

Bilal Mujtaba, Corey T. Jensen, Rizwan Aslam, Ahmed K. Elsayes, Vishnupriya Kuchana +2 more

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer(2024)10.1038/s43018-024-00726-z

N/A

0DataRank · unranked

58 citations

Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin +54 more